Ainos, Inc. (AIMD) vs Biofrontera Inc. (BFRI)
A side-by-side comparison of Ainos, Inc. and Biofrontera Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIMD
Ainos, Inc.
$1.34HealthcareDelayed quote: Oct 6, 2026, 11:23 AM EDT
BFRI
Biofrontera Inc.
$0.91HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — AIMD vs BFRI
growth of $100 · dividends reinvested · last 5yAIMD -99.5% (-64.7%/yr)BFRI -99.0% (-60.1%/yr)BFRI compounded faster over this window
AIMD BFRI
AIMD vs BFRI: by the numbers
- •BFRI is the larger company ($12M vs $10M market cap).
- •Both run net losses; BFRI's is the smaller (-13.78% vs -106283.32% net margin).
- •AIMD grew revenue faster over the past five years (49.62% vs 15.55% CAGR).
Metrics side by side
Valuation
| Metric | AIMD | BFRI |
|---|---|---|
| P/S ratio | 725.62 | 0.25 |
| P/B ratio | 3.01 | 1.95 |
Profitability
| Metric | AIMD | BFRI |
|---|---|---|
| Gross margin | -3767.20% | 84.45% |
| Operating margin | -11268.32% | -21.94% |
| Net margin | -106283.32% | -13.78% |
| ROE | -440.15% | -106.87% |
| ROIC | -80.51% | -32.27% |
Growth (annualized)
| Metric | AIMD | BFRI |
|---|---|---|
| Revenue CAGR (5Y) | 49.62% | 15.55% |
| Total return CAGR (5Y) | -58.50% | N/A |
Frequently asked
- Which has grown faster, AIMD or BFRI?
- Over the past five years, AIMD grew revenue faster — AIMD at a 49.62% CAGR versus BFRI at 15.55%.
Go deeper
Dig into the metrics
Ainos ROEBiofrontera ROEAinos operating marginBiofrontera operating marginAinos revenue growthBiofrontera revenue growthAinos free cash flowBiofrontera free cash flow
Ainos & Biofrontera appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.